Cancer News
Articles 11 - 20 of most recent articles
Sound Pharmaceuticals Files Second IND With The FDA For The Prevention Of Chemotherapy Induced Hearing Loss In Advanced Stage Cancer
Sound Pharmaceuticals (SPI) has filed an Investigational New Drug Application with the FDA for the clinical testing of a proprietary formulation of ebselen for the prevention of chemotherapy induced hearing loss or ototoxicity. The oral capsule containing ebselen, SPI-3005, will be tested in advanced stage lung cancer and head and neck cancer patients receiving platinum based chemotherapy.
Medical News Today – 11 hours, 40 minutes ago ¦ comment?
Sound Pharmaceuticals (SPI) has filed an Investigational New Drug Application with the FDA for the clinical testing of a proprietary formulation of ebselen for the prevention of chemotherapy induced hearing loss or ototoxicity. The oral capsule containing ebselen, SPI-3005, will be tested in advanced stage lung cancer and head and neck cancer patients receiving platinum based chemotherapy.
Medical News Today – 11 hours, 40 minutes ago ¦ comment?
Roswell Park Surgeons Perform 100th Bladder Cancer Robotic Surgery
The Minimally Invasive Surgical Center at Roswell Park Cancer Institute (RPCI) has performed its 100th robot-assisted radical cystectomy for advanced bladder cancer using the da Vinci® Surgical Robotic System which distinguishes RPCI as one of the world's premier academic institutions for the procedure. Khurshid A.
Medical News Today – 11 hours, 40 minutes ago ¦ comment?
The Minimally Invasive Surgical Center at Roswell Park Cancer Institute (RPCI) has performed its 100th robot-assisted radical cystectomy for advanced bladder cancer using the da Vinci® Surgical Robotic System which distinguishes RPCI as one of the world's premier academic institutions for the procedure. Khurshid A.
Medical News Today – 11 hours, 40 minutes ago ¦ comment?
Cancer Patient Survival Linked To The Checking Of More Lymph Nodes
Why do patients with gastric or pancreatic cancer live longer when they are treated at cancer centers or high-volume hospitals than patients treated at low-volume or community hospitals? New research from Northwestern University's Feinberg School of Medicine found that cancer patients have more lymph nodes examined for the spread of their disease if they are treated at hospitals performing more cancer surgeries or those designated as comprehensive cancer centers.
Medical News Today – 11 hours, 40 minutes ago ¦ comment?
Why do patients with gastric or pancreatic cancer live longer when they are treated at cancer centers or high-volume hospitals than patients treated at low-volume or community hospitals? New research from Northwestern University's Feinberg School of Medicine found that cancer patients have more lymph nodes examined for the spread of their disease if they are treated at hospitals performing more cancer surgeries or those designated as comprehensive cancer centers.
Medical News Today – 11 hours, 40 minutes ago ¦ comment?
Targeted Drug Boosts Survival Among Liver Cancer Patients
HealthDay - WEDNESDAY, July 23 (HealthDay News) -- The drug Nexavar canprolong the lives of people with liver cancer by an average of threemonths, new research shows.
Yahoo! – 14 hours, 53 minutes ago ¦ comment?
HealthDay - WEDNESDAY, July 23 (HealthDay News) -- The drug Nexavar canprolong the lives of people with liver cancer by an average of threemonths, new research shows.
Yahoo! – 14 hours, 53 minutes ago ¦ comment?
Lance Armstrong, top doctors launch cancer quest
Reuters - Cyclist and testicular cancer survivor Lance Armstrong joined forces with four former U.S. surgeons general on Wednesday to urge Americans to do more to prevent cancer and get recommended screening tests.
Yahoo! – 21 hours, 47 minutes ago ¦ comment?
Reuters - Cyclist and testicular cancer survivor Lance Armstrong joined forces with four former U.S. surgeons general on Wednesday to urge Americans to do more to prevent cancer and get recommended screening tests.
Yahoo! – 21 hours, 47 minutes ago ¦ comment?
Vytorin makers say cancer results likely an anomaly
Reuters - Cancer findings in a new study of cholesterol drug Vytorin are "likely to be an anomaly" unrelated to the drug, makers Merck & Co and Schering-Plough Corp said in a letter to doctors.
Yahoo! – 21 hours, 47 minutes ago ¦ comment?
Reuters - Cancer findings in a new study of cholesterol drug Vytorin are "likely to be an anomaly" unrelated to the drug, makers Merck & Co and Schering-Plough Corp said in a letter to doctors.
Yahoo! – 21 hours, 47 minutes ago ¦ comment?
Teen smokers want to quit but often fail
Reuters - Novice teenage smokers often make repeated attempts to quit smoking soon after they start, but most are unsuccessful, according to research funded by the Canadian Cancer Society.
Yahoo! – 22 hours, 23 minutes ago ¦ comment?
Reuters - Novice teenage smokers often make repeated attempts to quit smoking soon after they start, but most are unsuccessful, according to research funded by the Canadian Cancer Society.
Yahoo! – 22 hours, 23 minutes ago ¦ comment?
Protein Gives Doctors New Tool to Detect Melanoma
HealthDay - WEDNESDAY, July 23 (HealthDay News) -- Melanoma produces high levels ofa protein called IMP-3, which is not over-expressed in harmless moles,University of Rochester Medical Center researchers report.
Yahoo! – 22 hours, 36 minutes ago ¦ comment?
HealthDay - WEDNESDAY, July 23 (HealthDay News) -- Melanoma produces high levels ofa protein called IMP-3, which is not over-expressed in harmless moles,University of Rochester Medical Center researchers report.
Yahoo! – 22 hours, 36 minutes ago ¦ comment?
New drug prolongs survival of advanced kidney cancer
Reuters - Treatment with everolimus can significantly improve the progression-free survival of patients with advanced kidney cancer that has not responded to other treatments, according to a report in the online issue of The Lancet.
Yahoo! – Jul 23, 2008 5:11 PM [GMT] ¦ comment?
Reuters - Treatment with everolimus can significantly improve the progression-free survival of patients with advanced kidney cancer that has not responded to other treatments, according to a report in the online issue of The Lancet.
Yahoo! – Jul 23, 2008 5:11 PM [GMT] ¦ comment?
Merck Serono Receives European Approval For Broader Usage Of Erbitux In Metastatic Colorectal Cancer Including 1st-Line Treatment
Merck KGaA announced today that it has been granted approval by the European Commission for Erbitux® (cetuximab), to update its license for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing, KRAS wild-type mCRC (metastatic colorectal cancer) in combination with chemotherapy, and as a single agent in patients who have failed oxaliplatin- and irinotecan-based therapy and who are intolerant to irinotecan.
Medical News Today – Jul 23, 2008 4:00 PM [GMT] ¦ comment?
Merck KGaA announced today that it has been granted approval by the European Commission for Erbitux® (cetuximab), to update its license for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing, KRAS wild-type mCRC (metastatic colorectal cancer) in combination with chemotherapy, and as a single agent in patients who have failed oxaliplatin- and irinotecan-based therapy and who are intolerant to irinotecan.
Medical News Today – Jul 23, 2008 4:00 PM [GMT] ¦ comment?
